Business News • PR NewsWire • Cell Therapeutics Announces Results from Preclinical Study of Pixantrone (PIXUVRI®) Presented at the AACR-NCI-EORTC Meeting

Cell Therapeutics Announces Results from Preclinical Study of Pixantrone (PIXUVRI®) Presented at the AACR-NCI-EORTC Meeting

Cell Therapeutics Announces Results from Preclinical Study of Pixantrone (PIXUVRI®) Presented at the AACR-NCI-EORTC Meeting

SEATTLE, Oct. 21, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the presentation of findings from a preclinical study of PIXUVRI® (pixantrone) that suggest its mechanism of inducing tumor cell death is novel and distinct from that of...

View More : http://www.prnewswire.com/news-releases/cell-therapeutics-announces-results-from-preclinical-study-of-pixantrone-pixuvri...

Releted News by prnewswire

Team Falken Takes First In GT At ALMS Season-Ender, The 16th Annual Petit Le Mans

ThromboGenics' JETREA® Nominated for 2013 Prix Galien USA

LADY GAGA'S 'DO WHAT U WANT' FEATURING R KELLY OUT NOW!!

Les loteries INTERLOT : l'occasion exceptionnelle de remporter un appartement pour moins de 2 dollars !